Niloufar Mobashery Selected Research

Niloufar Mobashery Research Topics

17	Infections 01/2020 - 07/2013
11	Fibrosis (Cirrhosis) 01/2020 - 06/2014
6	Chronic Hepatitis C 01/2020 - 06/2014
5	Nausea 10/2016 - 09/2013
4	Diarrhea 04/2016 - 09/2013
3	Virus Diseases (Viral Diseases) 01/2020 - 06/2015
2	Hepatitis C 03/2019 - 09/2013
2	Vomiting 04/2016 - 06/2014
2	Anemia 06/2014 - 07/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2018
1	Coinfection 01/2017
1	Pruritus (Itching) 10/2016
1	Headache (Headaches) 10/2016
1	Fever (Fevers) 10/2016
1	Reinfection 12/2014
1	Viremia 09/2013
1	Exanthema (Rash) 07/2013
1	Septic Shock (Toxic Shock Syndrome) 11/2004

16	Ribavirin (Virazole)FDA LinkGeneric 03/2019 - 07/2013
9	ombitasvirIBA 03/2019 - 06/2015
9	Ritonavir (Norvir)FDA Link 03/2019 - 06/2015
9	paritaprevirIBA 03/2019 - 06/2015
8	InterferonsIBA 03/2019 - 07/2013
7	vaniprevirIBA 10/2016 - 07/2013
6	Antiviral Agents (Antivirals)IBA 03/2019 - 09/2013
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 09/2013
4	Pharmaceutical PreparationsIBA 01/2020 - 09/2013
3	dasabuvirIBA 02/2019 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2017 - 06/2015
2	peginterferon alfa-2b (Pegintron)FDA Link 10/2016 - 04/2016
2	grazoprevirIBA 12/2014 - 08/2014
1	glecaprevir and pibrentasvirIBA 01/2020
1	TabletsIBA 01/2020
1	glecaprevirIBA 01/2020
1	pibrentasvirIBA 01/2020
1	SofosbuvirIBA 03/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Alanine Transaminase (SGPT)IBA 11/2018
1	Darunavir (Prezista)FDA Link 01/2017
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2017
1	Raltegravir Potassium FDA Link 01/2017
1	dolutegravirIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 10/2016
1	Hepatitis C AntibodiesIBA 01/2016
1	peginterferon alfa-2a (Pegasys)FDA Link 02/2015

3	Therapeutics 10/2015 - 09/2013
2	Duration of Therapy 03/2019 - 11/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 11/2004